比較薬評価の宿主としてゼブラフィッシュ幼虫を用いた膵臓癌の患者由来異種異種移植片モデル

Overview

This protocol describes a virus-based dual fluorescence-labeled tumor xenograft model using larval zebrafish as hosts. This model mimics the pancreatic cancer microenvironment in vivo, providing a precise tool for assessing drug responses in personalized zPDX models.

Key Study Components

Area of Science

• Neuroscience
• Oncology
• Pharmacology

Background

• Larval zebrafish can mimic human tissue composition.
• The model enhances consistency in drug response analysis.
• Fluorescent labeling allows real-time tracking of cellular compositions.
• Improved survival of human cells in zebrafish extends observation time.

Purpose of Study

• To develop a more accurate model for drug testing in pancreatic cancer.
• To facilitate personalized medicine approaches.
• To assess pre-clinical tumor drug responses effectively.

Methods Used

• Use of larval zebrafish as hosts for tumor xenografts.
• Application of dual fluorescence labeling techniques.
• Real-time tracing of cellular compositions during drug testing.
• Genetic modification of zebrafish to enhance human cell survival.

Main Results

• The model successfully mimics the pancreatic cancer microenvironment.
• Fluorescent labeling improved tracking of drug responses.
• Increased survival time of human cells was observed.
• The approach shows promise for personalized medicine applications.

Conclusions

• The zebrafish model is a valuable tool for cancer research.
• It enhances the assessment of drug efficacy in personalized treatments.
• Future studies can build on this model for further advancements.

Frequently Asked Questions